In addition, the likelihood of clinically significant cancer increases with increasing serum PSA value, although this is a multifactorial phenomenon, as prostatic hyperplasia is more likely to result in an elevated PSA, and prostatic hyperplasia would decrease the sensitivity of standard biopsy. The gene discussed is KLK3; the disease is cancer.